ICUI

ICU Medical, Inc.

$182.11

1.82%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.

Source: Yahoo Finance
AI summary

Price & performance

1M+1.4%
3M+0.4%
YTD+20.1%
1Y+38.5%
52-week range—
Beta1.19
Full chart and returns against a benchmark

Q-Score

62/ 100

Quality against peers; 50 is the peer median.

Growth52
Risk69
Performance58
Valuation65
Profitability58
Leverage45
Sentiment50
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.2B-6.3%
Net income$732K
Net margin0.0%+5.0 pts
Historical fundamentals

Revenue exposure

39%of revenue from outside the US
United States61%
EMEA18%
APAC Domain10%
Regions, segments, customers and suppliers

Valuation

ICUIIndustryP/E75.4949.36P/S2.093.73EV/EBITDA17.3923.12P/B2.083.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate$2.15
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate